DAWN FY 2020 Earnings — Day One Biopharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

DAWNDay One Biopharmaceuticals, Inc.

$2B

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$155,000

Operating Income

-$14M

Net Income

-$41M

EPS (Diluted)

$-0.65

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$14M

Stock-Based Comp.

$526,000

Balance Sheet

Total Assets

$46M

Total Liabilities

$2M

Stockholders' Equity

$38M

Cash & Equivalents

$44M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$155,000	$0	—
Operating Income	-$14M	-$15M	+7.5%
Net Income	-$41M	-$13M	-220.6%